Loading...

SeqLL Inc.

SQLNASDAQ
Healthcare
Medical - Diagnostics & Research
$6.60
$-0.16(-2.38%)

SeqLL Inc. (SQL) Company Profile & Overview

Explore SeqLL Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

SeqLL Inc. (SQL) Company Profile & Overview

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMr. Daniel Robert Jones

Contact Information

781 460 6016
3 Federal Street, Billerica, MA, 01821

Company Facts

7 Employees
IPO DateAug 27, 2021
CountryUS

Frequently Asked Questions

;